Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.19 | 2.26 |
NAV | ₹13.94 | ₹166.87 |
Fund Started | 16 Aug 2023 | 13 Oct 2005 |
Fund Size | ₹949.45 Cr | ₹1429.17 Cr |
Exit Load | Exit load of 1%, if redeemed within 1 year. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.65% | 8.65% |
3 Year | - | 23.37% |
5 Year | - | 26.01% |
1 Year
3 Year
5 Year
Equity | 94.22% | 92.07% |
Cash | 5.66% | 7.36% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Suzlon Energy Ltd. | 4.08% |
GE Vernova T&D India Ltd. | 4.03% |
Info Edge (India) Ltd. | 3.90% |
Affle 3I Ltd. | 3.39% |
Bharat Electronics Ltd. | 3.37% |
Eternal Ltd. | 3.10% |
The Federal Bank Ltd. | 3.08% |
PB Fintech Ltd. | 3.03% |
Acutaas Chemicals Ltd. | 3.01% |
TVS Motor Company Ltd. | 2.98% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.13% |
Reliance Industries Ltd. | 6.61% |
State Bank of India | 5.34% |
Infosys Ltd. | 5.21% |
NTPC Ltd. | 4.87% |
HDFC Bank Ltd. | 4.57% |
Axis Bank Ltd. | 4.05% |
Bharti Airtel Ltd. | 3.53% |
Sun Pharmaceutical Industries Ltd. | 3.51% |
Dr. Reddy's Laboratories Ltd. | 3.06% |
Name | Hardick Bora | Sri Sharma |
Start Date | 25 Jan 2023 | 30 Apr 2021 |
Name
Start Date
Description | The Scheme seeks to achieve long term capital appreciation by investing predominantly in equity and equity related securities of Innovative Companies. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 16 Aug 2023 | 13 Oct 2005 |
Description
Launch Date